MYDRIACYL

This brand name is authorized in Brazil, Canada, Ecuador, Estonia, Hong Kong, Lithuania, New Zealand, Singapore, United Kingdom, United States

Active ingredients

The drug MYDRIACYL contains one active pharmaceutical ingredient (API):

1 Tropicamide UNII N0A3Z5XTC6 - TROPICAMIDE

Tropicamide is an anticholinergic which blocks the responses of the sphincter muscle of the iris and the ciliary muscle to cholinergic stimulation thus dilating the pupil (mydriasis). Read about Tropicamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MYDRIACYL Eye drops, solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01FA06	Tropicamide	S Sensory organs → S01 Ophthalmologicals → S01F Mydriatics and cycloplegics → S01FA Anticholinergics
Discover more medicines within S01FA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500902901178316
Country: CA	Health Products and Food Branch	Identifier(s): 00000981, 00001007
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.641-04-04
Country: EE	Ravimiamet	Identifier(s): 1123850
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 39070
Country: HK	Department of Health Drug Office	Identifier(s): 16911
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010021
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 942, 943
Country: SG	Health Sciences Authority	Identifier(s): 04715P, 04721P
Country: US	FDA, National Drug Code	Identifier(s): 0065-0355, 0998-0355